Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future (Q30432576)

7 November 2017

Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

7 November 2017

0 references

1 reference

non-alcoholic fatty liver

inferred from title

1 reference

1 reference

Emer Fitzpatrick

1

0 references

Anil Dhawan

object named as

Anil Dhawan

series ordinal

2

0 references

language of work or name

English

0 references

publication date

1 August 2014

1 reference

World Journal of Gastroenterology

7 November 2017

1 reference

7 November 2017

20

1 reference

7 November 2017

31

1 reference

7 November 2017

10851-10863

1 reference

Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography

7 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Feasibility of liver transient elastography with FibroScan using a new probe for obese patients

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Alteration of protein glycosylation in liver diseases

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Functional roles of N-glycans in cell signaling and cell adhesion in cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Cell-mediated rejection results in allograft loss after liver cell transplantation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Performance of transient elastography for the staging of liver fibrosis: a meta-analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Meta-analyses of FibroTest diagnostic value in chronic liver disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD).

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Non invasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Long-term follow-up of patients with NAFLD and elevated liver enzymes

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

The ins and outs of mitochondrial dysfunction in NASH.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Phases of biomarker development for early detection of cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Liver fibrosis in overweight patients

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Gallbladder emptying and somatostatin and cholecystokinin plasma levels in celiac disease.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors

20 June 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Sampling variability of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Metabolic, hormonal, oxidative, and inflammatory factors in pediatric obesity-related liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

High sensitivity C-reactive protein values do not reliably predict the severity of histological changes in NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Serum leptin levels, hepatic leptin receptor transcription, and clinical predictors of non-alcoholic steatohepatitis in obese bariatric surgery patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Comparison of blood tests for liver fibrosis specific or not to NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

The utility of the "NAFLD fibrosis score" in morbidly obese subjects with NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Hepatic artery resistance in alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

MRI and ultrasound for hepatic fat quantification:relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Nonalcoholic Fatty Liver Disease in Severely Obese Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I31.10851

Serum protein N-glycosylation in paediatric non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

N-glycan based biomarker distinguishing non-alcoholic steatohepatitis from steatosis independently of fibrosis.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Serum markers detect the presence of liver fibrosis: a cohort study.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

The utility of radiological imaging in nonalcoholic fatty liver disease.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4138464

A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease

26 November 2018

1 reference

12 December 2020

Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2

1 reference

12 December 2020

Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis

1 reference

12 December 2020

Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease

1 reference

12 December 2020

A position statement on NAFLD/NASH based on the EASL 2009 special conference

1 reference

12 December 2020

Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging

1 reference

12 December 2020

Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease

1 reference

12 December 2020

Abnormal surface distribution of the human asialoglycoprotein receptor in cirrhosis

1 reference

12 December 2020

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

12 December 2020

Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers

1 reference

12 December 2020

Natural history of NAFLD: remarkably benign in the absence of cirrhosis

1 reference

12 December 2020

Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease

1 reference

12 December 2020

[Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future]

1 reference

12 December 2020

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis

1 reference

12 December 2020

Adipokines and cytokines in non-alcoholic fatty liver disease

1 reference

12 December 2020

Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD

1 reference

12 December 2020

Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease

1 reference

12 December 2020

Gene expression profiling of non-alcoholic steatohepatitis using gene set enrichment analysis

1 reference

12 December 2020

Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis

1 reference

12 December 2020

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

1 reference

12 December 2020

Physical state of meal affects gastric emptying, cholecystokinin release and satiety

1 reference

12 December 2020

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

1 reference

12 December 2020

Acute lymphoblastic leukemia presenting as acute hepatic failure in childhood

1 reference

12 December 2020

Analysis of adipokine concentrations in paediatric non-alcoholic fatty liver disease

1 reference

12 December 2020

Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver disease

1 reference

12 December 2020

Heterogeneity of hemochromatosis in Italy

1 reference

12 December 2020

Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers

1 reference

12 December 2020

Predictors of non-alcoholic fatty liver disease in obese children

1 reference

12 December 2020

FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest

1 reference

12 December 2020

Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound

1 reference

12 December 2020

Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat

1 reference

12 December 2020

Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease

1 reference

12 December 2020

Acute myelogenous leukemia in Down's syndrome: report of a single pediatric institution using a BFM treatment strategy

1 reference

12 December 2020

10.3748/WJG.V20.I31.10851

Identifiers

DOI

1 reference

7 November 2017

1 reference

7 November 2017

1 reference

PMCID

4138464